Hopkins researchers are developing a virtual cell lab to model real-time cell behavior—accelerating how we study cancer and test treatments. The work is made possible through support from the JKTG Foundation. 🧬 Read more: hopkinsmedicine.org/news/newsroom/…

Lincoln put it best: calling a tail a leg doesn’t make it one. 🐕Truth isn’t what we want to believe—it’s reality. Read more in the latest #TedsTake 👉 jktgfoundation.org/post/ted-s-tak…

🚦Episode 2 of Driving Research is here! Ted Giovanis talks with Dr. Laura Heiser of OHSU about smarter therapies for tough-to-treat cancers and what mechanics and cancer researchers have in common. ▶️ Watch: youtube.com/watch?v=oaE1JT…

September is Healthy Aging Month. For Ted Giovanis, it’s not about age—it’s about drive. 🏁 #HealthyAging #KeepGoing 🔗 bit.ly/4dMSC5F

New research shows progress against “sleeper cells” — dormant cancer cells that can spark recurrence and drive metastatic breast cancer. At JKTG, this is why we focus on understanding and targeting metastasis: it’s the key to saving lives. 🔗 independent.co.uk/news/health/br…

📣 Join us Oct. 15 in Washington, D.C. for the JKTG Foundation’s Annual Symposium. This year’s focus: improving breast cancer outcomes by revealing and targeting tumor immune interactions. Register here: bit.ly/45hwK05

Make time to laugh. In a recent podcast, Ted shares the importance of humor. It’s essential in racing, leadership and life // 🔗bit.ly/4m28SCA

"By fostering collaboration and freedom, we create meaningful ways to turn insights into advances in human health.” – Ted Giovanis

More timely now than when he wrote it last year: “AI doesn’t erase bias — it reflects it.” – Ted Giovanis As AI races ahead, Ted’s take reminds us why guiding technology with care matters. 🔗 jktgfoundation.org/post/ted-s-tak…

The power behind JKTG’s support of the new “virtual cell lab,” fast-tracking cancer breakthroughs.🔗jktgfoundation.org/post/driving-r…

Risk + resilience aren’t just buzzwords — they’re essential to the future of health care. Read more in a recent JACR article, by Ted Giovanis and others on why embracing adaptability and flexible funding is key to accelerating innovation.🔗bit.ly/45b1KhB

Driving Research! JKTG Foundation-funded study finds tiny iron-based nanoparticles could more safely detect & treat cancer. Several types showed no lasting liver or kidney harm 60 days post-injection. Published in Frontiers in Toxicology – read more: bit.ly/4qvMhl4

What happens when a racecar driver funds groundbreaking cancer research? Dr. Paul Macklin brings a math mindset to cancer research + shares how teaming up with Ted Giovanis brings faster results + brings cool people together for very cool results. Listen: buzzsprout.com/2508148/episod…

Discovery takes persistence — and a bit of curiosity. Every breakthrough starts with someone asking “what if?” #JKTGFoundation #CancerResearch #DrivingResearch

Safer imaging. Smarter science. JKTG-supported researchers at Johns Hopkins are advancing iron nanoparticle technology for cancer detection. #DrivingResearch #JKTGFoundation bit.ly/4qvMhl4

When a racecar driver funds cancer research, things move fast. 🏎️Dr. Paul Macklin (Indiana Univ.) shares how teaming up with Ted Giovanis brings math, momentum, and innovation to the lab. New episode out now 🎧 buzzsprout.com/2508148/episod…

It’s Healthy Aging Month — but let’s reframe it: health isn’t about slowing down; it’s about moving smart. Here’s to meaningful aging, full of purpose and possibility. #HealthyAging #JKTGFoundation

Gratitude moment: to every scientist, student, advocate and partner who says ‘yes’ to the hard questions. Your commitment fuels better outcomes. Thank you for being part of the journey. #ThankYou #ResearchMatters

Gratitude drives progress. This Thanksgiving, we’re thankful for the scientists, clinicians, and collaborators who ask bold questions and pursue better answers. 💛 #Thanksgiving #ResearchMatters

Proud to be featured by IMSA + backed by TeamTGM this #GivingTuesday. Looking to make an impact with your donation? Ted’s giving guide is a must-read: bit.ly/44JYHfH